These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11424054)

  • 1. [Juvenile myoclonic epilepsy].
    Salas-Puig J; Calleja S; Jiménez L; González-Delgado M
    Rev Neurol; 2001 May 16-31; 32(10):957-61. PubMed ID: 11424054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy.
    Koepp MJ; Thomas RH; Wandschneider B; Berkovic SF; Schmidt D
    Expert Rev Neurother; 2014 Jul; 14(7):819-31. PubMed ID: 24931665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The history of juvenile myoclonic epilepsy.
    Genton P; Gelisse P
    Epilepsy Behav; 2013 Jul; 28 Suppl 1():S2-7. PubMed ID: 23756475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in diagnosis of epilepsy of Janz and its implications.
    Jha S; Mathur VN; Mishra VN
    Neurol India; 2002 Dec; 50(4):467-9. PubMed ID: 12577097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
    Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
    Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile myoclonic epilepsy].
    Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
    Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of valporic acid efficacy in familial versus sporadic cases of juvenile myoclonic epilepsy.
    Motamedi M; Mohammad Ali S; Rahmat M
    Neurol India; 2006 Jun; 54(2):186-9; discussion 189. PubMed ID: 16804266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonic status epilepticus in juvenile myoclonic epilepsy.
    Larch J; Unterberger I; Bauer G; Reichsoellner J; Kuchukhidze G; Trinka E
    Epileptic Disord; 2009 Dec; 11(4):309-14. PubMed ID: 20045780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
    Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
    Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy.
    Park KM; Kim SH; Nho SK; Shin KJ; Park J; Ha SY; Kim SE
    J Clin Neurosci; 2013 Aug; 20(8):1079-82. PubMed ID: 23673144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India.
    Mehndiratta MM; Aggarwal P
    Seizure; 2002 Oct; 11(7):431-6. PubMed ID: 12237068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
    Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
    Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.
    Senf P; Schmitz B; Holtkamp M; Janz D
    Neurology; 2013 Dec; 81(24):2128-33. PubMed ID: 24212391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
    Bodenstein-Sachar H; Gandelman-Marton R; Ben-Zeev B; Chapman J; Blatt I
    Acta Neurol Scand; 2011 Jul; 124(1):22-7. PubMed ID: 21208196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile myoclonic epilepsy and idiopathic photosensitive occipital lobe epilepsy: is there overlap?
    Taylor I; Marini C; Johnson MR; Turner S; Berkovic SF; Scheffer IE
    Brain; 2004 Aug; 127(Pt 8):1878-86. PubMed ID: 15201194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.